Singular Genomics Systems, Inc.
NASDAQ:OMIC
23.3 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Singular Genomics Systems, Inc. |
Symbool | OMIC |
Munteenheid | USD |
Prijs | 23.3 |
Beurswaarde | 58,149,577 |
Dividendpercentage | 0% |
52-weken bereik | 5.34 - 23.3 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Andrew Spaventa |
Website | https://singulargenomics.com |
An error occurred while fetching data.
Over Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)